Monoclonal antibody therapy in the treatment of Reye's syndrome
- 30 November 1992
- journal article
- Published by Elsevier BV in Medical Hypotheses
- Vol. 39 (3), 238-242
- https://doi.org/10.1016/0306-9877(92)90115-s
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole bloodBiochemical and Biophysical Research Communications, 1991
- Plasma Tumor Necrosis Factor α Predicts Decreased Long‐Term Survival in Severe Alcoholic HepatitisAlcohol: Clinical and Experimental Research, 1990
- The regulation of fatty acid and branched-chain amino acid oxidation in cancer cachectic rats: A proposed role for a cytokine, eicosanoid, and hormone trilogyBiochemical Medicine and Metabolic Biology, 1989
- Inhibition of target cell mitochondrial electron transfer by tumor necrosis factorFEBS Letters, 1989
- The release of tumor necrosis factor from endotoxin-stimulated rat Kupffer cells is regulated by prostaglandin E2 and dexamethasoneJournal of Hepatology, 1988
- Uptake and modification of125I-lipopolysaccharide by isolated rat Kupffer cellsHepatology, 1988
- ENHANCED TUMOUR NECROSIS FACTOR AND INTERLEUKIN-1 IN FULMINANT HEPATIC FAILUREThe Lancet, 1988
- Adult Reye's syndromeAnnals of Emergency Medicine, 1988
- Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.The Journal of Experimental Medicine, 1986
- INFLUENCE OF NEOMYCIN AND INGESTED ENDOTOXIN IN THE PATHOGENESIS OF CHOLINE DEFICIENCY CIRRHOSIS IN THE ADULT RATThe Journal of Experimental Medicine, 1964